Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4750131
Max Phase: Preclinical
Molecular Formula: C13H16N6O5
Molecular Weight: 336.31
Molecule Type: Unknown
Associated Items:
ID: ALA4750131
Max Phase: Preclinical
Molecular Formula: C13H16N6O5
Molecular Weight: 336.31
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NC2COC2)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C13H16N6O5/c14-10-6-11(16-3-15-10)19(4-17-6)13-8(21)7(20)9(24-13)12(22)18-5-1-23-2-5/h3-5,7-9,13,20-21H,1-2H2,(H,18,22)(H2,14,15,16)/t7-,8+,9-,13+/m0/s1
Standard InChI Key: JQZXCSIXUVOYDD-QRIDJOKKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 336.31 | Molecular Weight (Monoisotopic): 336.1182 | AlogP: -2.46 | #Rotatable Bonds: 3 |
Polar Surface Area: 157.64 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.97 | CX Basic pKa: 4.92 | CX LogP: -2.51 | CX LogD: -2.51 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.48 | Np Likeness Score: 0.53 |
1. Tosh DK,Brackett CM,Jung YH,Gao ZG,Banerjee M,Blagg BSJ,Jacobson KA. (2021) Biological Evaluation of 5'-(N-Ethylcarboxamido)adenosine Analogues as Grp94-Selective Inhibitors., 12 (3): [PMID:33738064] [10.1021/acsmedchemlett.0c00509] |
Source(1):